17 The risk of venous thromboembolism after cystectomy and prostatectomy with or without a pelvic lymph-node dissection

17 The risk of venous thromboembolism after cystectomy and prostatectomy with or without a pelvic lymph-node dissection

Saved in:

Bibliographic Details
Main Authors:	O. Akre, J. Rautiola, J. Björklund, R. Zelic, F. Pellegrino, P.H. Vincent, M. Aly, H. Falconer, P. Wiklund
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168325000205
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk factors for lymphatic leakage following radical cystectomy and pelvic lymph node dissection in patients with muscle-invasive bladder cancer
by: Zixuan Xue, et al.
Published: (2025-01-01)

14 PSA based intermediate endpoints to compare cancer specific survival difference between radiotherapy and radical prostatectomy for the treatment of localized prostate cancer
by: P. Wiklund, et al.
Published: (2025-01-01)

Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection
by: Alexander Winter, et al.
Published: (2012-01-01)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
by: Anthony Van Baelen, et al.
Published: (2012-01-01)

Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
by: Daniar K. Osmonov, et al.
Published: (2014-01-01)

Venous thromboembolic events: case history
by: T.V. Shelkovnikova, et al.
Published: (2019-11-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Maria I. Zervou, et al.
Published: (2025-02-01)

Venous thromboembolism still leads on maternal death
by: Amelia Shard, et al.
Published: (2025-01-01)

Racial disparities in extended venous thromboembolism prophylaxis after hysterectomy.
by: Wenbo Wu, et al.
Published: (2025-01-01)

Post‐operative incidence of lymphedema after RARP with or without extended pelvic lymph node dissection in a cohort study
by: Andries Clinckaert, et al.
Published: (2025-01-01)

Radical Cystectomy and Lymphadenectomy to Two Patients with Pelvic Kidney: Surgical Pitfalls and Considerations
by: I. Adamakis, et al.
Published: (2013-01-01)

Response to Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Bengt Zöller, et al.
Published: (2025-02-01)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
by: Roberto C. Montoya, et al.
Published: (2012-01-01)

Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy
by: Shalini Jain Bagaria, et al.
Published: (2011-01-01)

Anticoagulation in venous thromboembolism in Behçet’s syndrome: friend or foe?
by: Rosaria Talarico, et al.
Published: (2024-12-01)

Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
by: Rafaela Vostatek, et al.
Published: (2024-12-01)

Causal relationship between educational attainment and the occurrence of venous thromboembolism
by: Sitong Guo, et al.
Published: (2025-02-01)

Venous thromboembolism in bullous pemphigoid: current evidence and update on systematic review
by: Atheer G. Almutairi, et al.
Published: (2025-01-01)

Can Neutrophil-Lymphocyte Ratio and Lymph Node Density Be Used as Prognostic Factors in Patients Undergoing Radical Cystectomy?
by: Abdullah Demirtaş, et al.
Published: (2013-01-01)

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
by: Marte Svalastoga, et al.
Published: (2025-01-01)

Enhancing Venous Thromboembolism Risk Prediction through Novel Biomarkers and Inflammatory Indicators
by: Zainab Wahab Al-Maaroof
Published: (2024-12-01)

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries
by: Mengchao Wei, et al.
Published: (2025-01-01)

RISK FACTORS FOR THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH UNCOMPLICATED ACUTE CALCULOUS CHOLECYSTITIS
by: Mariya Kavka
Published: (2023-10-01)

A new risk assessment model of venous thromboembolism by considering fuzzy population
by: Xin Wang, et al.
Published: (2024-12-01)

Self-Retraction Clamp for Dissection of the Posterior Prostatic Fossa During Radical Retropubic Prostatectomy
by: Aria F. Olumi
Published: (2004-01-01)

Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
by: Brian Hu, et al.
Published: (2018-01-01)

Robotic-Assisted Dissection of Bulky Lymph Nodes in Cervical Cancer
by: Ahmet Göçmen, et al.
Published: (2014-01-01)

Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer
by: V. V. Astashov, et al.
Published: (2023-06-01)

General practitioner use of D-dimer in suspected venous thromboembolism: historical cohort study in one geographical region in the Netherlands
by: Angel M R Schols, et al.
Published: (2019-05-01)

Evaluation of Risk Factors of Venous Thromboembolism in Imam Sadiq Teaching Hospital at Babylon City
by: Intisar Mahdi Kadhim Almurshedi, et al.
Published: (2022-11-01)

Evaluating chemical venous thromboembolism prophylaxis in trauma patients at a single Australian center
by: Natalie Quarmby, et al.
Published: (2024-09-01)

Risk of Venous Thromboembolism in Patients Nursed at Home or in Long-Term Care Residential Facilities
by: Guido Arpaia, et al.
Published: (2011-01-01)

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)

Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
by: Jonatan Ahrén, et al.
Published: (2025-03-01)

Circulating, Extracellular Vesicle-Associated Tissue Factor in Cancer Patients with and without Venous Thromboembolism
by: Valentina Lami, et al.
Published: (2025-01-01)

Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
by: Nikola Vladic, et al.
Published: (2025-01-01)

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
by: Wil L. Santivasi, et al.
Published: (2014-01-01)

Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
by: Daniella Veloria, et al.
Published: (2025-03-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)